SPECIAL NOTICE
A -- Draft Solicitation. Please send all comment to Roger.K.Batchelor2.civ@mail.mil, comments are welcome until 12pm on September 4th.
- Notice Date
- 8/13/2014
- Notice Type
- Special Notice
- Contracting Office
- US Army Medical Research Acquisition Activity, ATTN: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014
- ZIP Code
- 21702-5014
- Solicitation Number
- W81XWH14MTEC
- Archive Date
- 8/13/2015
- Point of Contact
- Roger Keith Batchelor II, 301-619-2630
- E-Mail Address
-
US Army Medical Research Acquisition Activity
(roger.k.batchelor2.civ@mail.mil)
- Small Business Set-Aside
- N/A
- Description
- A Medical Technology Enterprise Consortium (MTEC) will be formed to augment the current capabilities of the US Army Medical Research and Material Command (MRMC) through a non-profit 501(c)(3) corporation that will have prime contractor responsibility as a consortium of small businesses, large businesses, universities, venture capital (VC) firms, and other non-profit entities. MRMC will fund this corporation through a renewable, ten-year Section 845 Other Transactions Agreement (OTA) and an optional FAR task order contract, which will allow the company to contract for goods and services that address four command requirements: 1) Research and prototyping, 2)Capitalization of private sector technology opportunities, 3) Technology transfer and commercialization of command intellectual property, 4)Procurement and production of military stocks (FAR Option). The Consortium will be organized under the National Cooperative Research and Production Act (NCRPA) authorized by Congress in 1993. This Act promotes innovation, facilitates trade, and strengthens competitiveness of the US through joint ventures and consortia. By filing a written notification, simultaneously with the Attorney General and the Federal Trade Commission disclosing the identities of the parties and the nature and objectives of the venture, theconsortium can invoke the Act's provision limiting the recovery of antitrust plaintiffs to actual damages under specific circumstances. This minimizes the antitrust risk to industry and academia organizations that partner to better leverage their capabilities to achieve the objectives of the Enterprise under the OTA. This covers Consortium Members for research, development and production. Awards made using the Other Transaction Agreement occur using two distinct authorities: 10 USC 2371, Section 845 of the 1994 Defense Authorization Act, authorized the research and development leading to prototypes directly relevant to current or proposed weapons systems, and Section 822 of the 2002 Defense Authorization Act authorized follow-on production of completed prototypes under a sole source FAR contract to the qualified recipient of the successful prototype project. Military medical technologies are included within the definition of Defense Weapons Systems. The 2012 North American Industrial Classification System (NAICS) code applicable to this effort are as followed: NAICS 32541: Pharmaceutical and Medicine Manufacturing, NAICS 54171: Research and Development in the Physical, Engineering, and Life Sciences and NAICS 54111: Management of Companies and Enterprises. This proposal is unrestricted and all qualified, responsive, and responsible firms may compete. It is the Offerors responsibility to monitor the FedBizOps website for all information. You must be registered in System for Award Management (SAM) Databases, to receive a Government contract award. You may register at for SAM at: https://www.sam.gov/portal/public/SAM/ Plans of the DRAFT- solicitation is anticipated to be announced at the 2014 Military Health System Research Symposium (MHSRS). You may register at: http://mhsrs.com/
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/USA/USAMRAA/DAMD17/W81XWH14MTEC/listing.html)
- Record
- SN03463924-W 20140815/140814000242-0d2d936231e6688475ab0a02943bcc89 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |